Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001127602-19-002480)

Filing Details

Accession Number:
0001127602-19-002480
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-22 17:01:53
Reporting Period:
2016-07-01
Accepted Time:
2019-01-22 17:01:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237334 Christopher Causey C/O United Therapeutics Corporation
1040 Spring Street
Silver Spring MD 20910		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-01 500 $51.77 1,605 No 4 M Direct
Common Stock Disposition 2016-07-01 500 $108.89 1,105 No 4 D Direct
Common Stock Disposition 2017-08-03 580 $127.48 3,295 No 4 S Direct
Common Stock Acquisiton 2019-01-18 750 $63.90 1,725 No 4 M Direct
Common Stock Disposition 2019-01-18 750 $115.75 975 No 4 D Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 S Direct
No 4 M Direct
No 4 D Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Share Tracking Award Disposition 2016-07-01 500 $0.00 500 $51.77
Common Stock Share Tracking Award Disposition 2019-01-18 750 $0.00 750 $63.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,500 2011-06-28 2020-06-28 No 4 M Direct
14,250 2014-06-26 2023-06-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 0 Indirect By Ugma Account
Footnotes
  1. This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
  2. This transaction was inadvertently omitted from the reporting person's filings due to an administrative error.
  3. This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.